Chronic Hepatitis C
Angiogenic activation in inflamed liver is linked to hepatocyte growth factor
Published in Hepatitis Weekly, May 26th, 2003
Researchers in Spain believe hepatocyte growth factor (HGF) controls angiogenesis in the inflamed liver of people with chronic hepatitis C by modulating growth factors known to regulate endothelial cell adhesion and migration. The knowledge of how proangiogenic mechanisms influence the pathogenesis of chronic hepatitis C could eventually lead investigators to the development of new treatment modalities.
In depth analyses of liver biopsies provided clues for how angiogenic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-05-26)
More Articles from Hepatitis Weekly
- Neonatal Medicine
Vertically transmitted hepatitis C virus infection generates mild liver disease - Pediatrics
T cell ratios predict how children with chronic hepatitis B respond to therapy - Antigen Processing
HLA class II alleles influence the natural history of hepatitis C virus illness - Biomarkers
Elevated alpha-fetoprotein is a benign familial condition in some people - Hepatocellular Carcinoma
Osteopontin is a biomarker and therapeutic target for HBV-related liver cancer - Virology
RNA interference inhibits hepatitis B virus replication and expression - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
